BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21785118)

  • 21. Alphafetoprotein in screening for congenital hypothyroidism.
    Shawky RM; Abd el-Fattah S; el-din Azzam ME; Rafik MM; Osman A
    East Mediterr Health J; 2001; 7(1-2):171-80. PubMed ID: 12596967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel therapeutic paradigm to treat congenital hypothyroidism.
    Mathai S; Cutfield WS; Gunn AJ; Webster D; Jefferies C; Robinson E; Hofman P
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):142-7. PubMed ID: 18598275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic blood markers reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Acta Med Hung; 1991; 48(1-2):33-43. PubMed ID: 1813856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mylicon drops in the treatment of infant colic.
    Becker N; Lombardi P; Sidoti E; Katkin LS
    Clin Ther; 1988; 10(4):401-5. PubMed ID: 3079007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of timing and dose of thyroid hormone replacement on mental, psychomotor, and behavioral development in children with congenital hypothyroidism.
    Bongers-Schokking JJ; de Muinck Keizer-Schrama SM
    J Pediatr; 2005 Dec; 147(6):768-74. PubMed ID: 16356429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Goserelin-induced transient thyrotoxicosis in a hypothyroid woman on L-thyroxine replacement.
    van Bon AC; Wiersinga WM
    Neth J Med; 2008 Jun; 66(6):256-8. PubMed ID: 18689910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic markers in blood reflecting thyroid hormone effect at peripheral tissue level in patients receiving levothyroxine replacement for hypothyroidism.
    Földes J; Tarján G; Bános C; Németh J; Varga F; Büki B
    Exp Clin Endocrinol; 1992; 99(3):129-33. PubMed ID: 1526260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The therapy of congenital hypothyroidism].
    Tatò L; Antoniazzi F; Costantini E; Zamboni G; Bertoldi C
    Ann Ist Super Sanita; 1994; 30(3):325-8. PubMed ID: 7879999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treating congenital hypothyroidism--which levothyroxine?
    Deladoëy J; Van Vliet G
    Nat Rev Endocrinol; 2013 May; 9(5):257-8. PubMed ID: 23458784
    [No Abstract]   [Full Text] [Related]  

  • 30. Congenital hypothyroidism: diagnosis, treatment, and prognosis.
    Postellon DC; Abdallah A
    Compr Ther; 1986 Jan; 12(1):67-71. PubMed ID: 3081294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial treatment dose of L-thyroxine in congenital hypothyroidism.
    Selva KA; Mandel SH; Rien L; Sesser D; Miyahira R; Skeels M; Nelson JC; Lafranchi SH
    J Pediatr; 2002 Dec; 141(6):786-92. PubMed ID: 12461494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simethicone in the treatment of infant colic: a randomized, placebo-controlled, multicenter trial.
    Metcalf TJ; Irons TG; Sher LD; Young PC
    Pediatrics; 1994 Jul; 94(1):29-34. PubMed ID: 8008533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effectiveness and cost-effectiveness of the use of the thyroxine/thyroxine-binding globulin ratio to detect congenital hypothyroidism of thyroidal and central origin in a neonatal screening program.
    Lanting CI; van Tijn DA; Loeber JG; Vulsma T; de Vijlder JJ; Verkerk PH
    Pediatrics; 2005 Jul; 116(1):168-73. PubMed ID: 15995048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of therapeutic effect of the growth of children with hypothyroidism.
    Bajracharya BL; Baral MR; Thapa Chhetri P
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):329-33. PubMed ID: 18603928
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital hypothyroidism in a child with unsuspected familial dysalbuminemic hyperthyroxinemia caused by a mutation (R218H) in the human albumin gene.
    Pohlenz J; Sadow PM; Koffler T; Schönberger W; Weiss RE; Refetoff S
    J Pediatr; 2001 Dec; 139(6):887-91. PubMed ID: 11743520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Growth in children with impairment of thyroid gland function].
    Hníková O
    Cas Lek Cesk; 1995 Mar; 134(6):170-2. PubMed ID: 7758067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the current threshold level for screening for congenital hypothyroidism too high? An audit of the clinical evaluation, confirmatory diagnostic tests and treatment of infants with increased blood spot thyroid-stimulating hormone concentrations identified on newborn blood spot screening in Wales.
    Pryce RA; Gregory JW; Warner JT; John R; Bradley D; Evans C
    Arch Dis Child; 2007 Nov; 92(11):1048. PubMed ID: 17846034
    [No Abstract]   [Full Text] [Related]  

  • 38. [Screening in specific categories of neonates exposed to congenital hypothyroidism].
    Beń-Skowronek I; Kucharska A; Hilczer M; Ołtarzewski M; Szalecki M; Walczak M; Jackowska T; Lewiński A; Bossowski A
    Pediatr Endocrinol Diabetes Metab; 2016 Jun; 21(3):122-6. PubMed ID: 27275767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Episodes of overtreatment during the first six months in children with congenital hypothyroidism and their relationships with sustained attention and inhibitory control at school age.
    Alvarez M; Iglesias Fernández C; Rodríguez Sánchez A; Dulín Lñiguez E; Rodríguez Arnao MD
    Horm Res Paediatr; 2010; 74(2):114-20. PubMed ID: 20395659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of infantile colic with surface active substance (simethicone).
    Danielsson B; Hwang CP
    Acta Paediatr Scand; 1985 May; 74(3):446-50. PubMed ID: 3890465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.